ReviewAdvanced drug delivery reviews2022

Delivery of CRISPR-Cas9 system for screening and editing RNA binding proteins in cancer.

Jingyue Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.